EMAIL THIS PAGE TO A FRIEND

Acta biochimica et biophysica Sinica

Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment.


PMID 26058582

Abstract

Excessive exposure to infrasound, a kind of low-frequency but high-intensity sound noise generated by heavy transportations and machineries, can cause vibroacoustic disease which is a progressive and systemic disease, and finally results in the dysfunction of central nervous system. Our previous studies have demonstrated that glial cell-mediated inflammation may contribute to infrasound-induced neuronal impairment, but the underlying mechanisms are not fully understood. Here, we show that cannabinoid (CB) receptors may be involved in infrasound-induced neuronal injury. After exposure to infrasound at 16 Hz and 130 dB for 1-14 days, the expression of CB receptors in rat hippocampi was gradually but significantly decreased. Their expression levels reached the minimum after 7- to 14-day exposure during which the maximum number of apoptotic cells was observed in the CA1. 2-Arachidonoylglycerol (2-AG), an endogenous agonist for CB receptors, reduced the number of infrasound-triggered apoptotic cells, which, however, could be further increased by CB receptor antagonist AM251. In animal behavior performance test, 2-AG ameliorated the infrasound-impaired learning and memory abilities of rats, whereas AM251 aggravated the infrasound-impaired learning and memory abilities of rats. Furthermore, the levels of proinflammatory cytokines tumor necrosis factor alpha and interleukin-1β in the CA1 were upregulated after infrasound exposure, which were attenuated by 2-AG but further increased by AM251. Thus, our results provide the first evidence that CB receptors may be involved in infrasound-induced neuronal impairment possibly by affecting the release of proinflammatory cytokines.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2500190
Anti-Cannabinoid receptor 1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
C1108 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
C2866 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
C1233 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
SAB2500191
Anti-Cannabinoid receptor 2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
C1358 Anti-Cannabinoid Receptor 2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
C1483 Anti-Cannabinoid Receptor 2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
SAB1305934
ANTI-CB1 (CENTER) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1306696
ANTI-CB2(C-TERMINAL) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2502004
Anti-CNR1 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2502003
Anti-CNR1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405638
Anti-CNR1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4500345
Anti-CNR1 antibody produced in rabbit, affinity isolated antibody
HPA028718
Anti-CNR2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500346
Anti-CNR2 antibody produced in rabbit, affinity isolated antibody
WH0001268M1
Monoclonal Anti-CNR1 antibody produced in mouse, clone 2F9, purified immunoglobulin, buffered aqueous solution
SAB1403683
Monoclonal Anti-CNR1, (N-terminal) antibody produced in mouse, clone 1F9, purified immunoglobulin, buffered aqueous solution
WH0001269M1
Monoclonal Anti-CNR2 antibody produced in mouse, clone 3C7, purified immunoglobulin, buffered aqueous solution